Condition: Leiomyoma, Uterine · Leiomyoma · Fibroid · Sponsor: University of California, San Francisco
The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
This description comes directly from the study's public registry record.
Study Coordinator · (510) 788-0545 · plumstudy@ucsf.edu
Lisa Abinanti · lisa.abinanti@ucsf.edu
Always discuss trial participation with your own doctor first.
| University of California, Los Angeles | Los Angeles, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| University of Mississippi Medical Center | Jackson, Mississippi, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06143631